What does Shin Nippon Biomedical Laboratories do with its cash?

Cash conversion (operating CF ÷ operating income)

313.8%

Cash vs. profit gap

¥3.76B（純利益の 82.3%）

Shareholder returns

of net income 45.6% · of FCF 69.7%

Shareholder payments — dividends

of net income 45.6% · of FCF 69.7%

CapEx intensity (capex ÷ revenue)

16.4%

Investing CF relative to operating CF

81.6%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

• Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
• Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
• Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.